LYZZ Capital: A global healthcare-focused VC/PE firm with a seasoned team of investment and medical experts.
Location
Shanghai, CN
Founded
2014
Lyzz Capital is a global healthcare-dedicated venture capital and private equity firm, actively investing from funds totaling over $600 million. The firm focuses on both USD and RMB investments, targeting various stages of healthcare companies. Lyzz Capital's typical investment rounds include Series A, B, and D, demonstrating their commitment to supporting companies at different growth phases.
The firm's team comprises highly experienced investment and operating professionals from leading pharmaceutical/biotech companies and Wall Street firms, bringing strong scientific and medical expertise. Notable portfolio companies include Jumpcode Genomics, Neurelis, Onchilles Pharma, OncoMyx Therapeutics, Viron, and Wugen. Lyzz Capital's decade-long collaborative approach and industry knowledge position them as valuable partners for healthcare startups.
Lyzz Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
